Acadia Pharmaceuticals Inc (ACAD): Operating Cash Flow
$109.84M
Year ended 2025-12-31
$160.32M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $109.84M | -30.4% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $157.72M | +844.3% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $16.70M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$114.03M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$125.66M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$136.17M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$151.13M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$167.47M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$217.76M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$208.41M | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2012-12-31 and 2016-12-31. | |||
| 2012-12-31 | -$21.63M | n/m | 2013-03-12, From 2012-01-01 |
| 2011-12-31 | -$19.90M | n/m | 2013-03-12, From 2011-01-01 |
| 2010-12-31 | -$10.70M | n/m | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | -$13.73M | n/a | 2012-03-06, From 2009-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $109.84M | -30.4% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $257.63M | +2.4% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$189.55M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$268.58M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$27.00M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $185.22M | +189.3% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $348.20M | +58.4% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $179.55M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $329.32M | +60.7% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗